期刊
CURRENT CANCER DRUG TARGETS
卷 13, 期 9, 页码 915-929出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/15680096113136660097
关键词
BCL-2; Cancer stem cell; drug resistance; EMT; microRNA; NF-kappa B; P-glycoprotein
类别
资金
- [NSFC-81030044]
- [2010CB 529300]
- [2010CB529302]
- [2010CB529305]
- [2010CB529306]
- [863-2012AA02A203]
- [81272343]
- [81225003]
- [81172096]
Overcoming intrinsic and acquired drug resistance is a major challenge in treating cancer. Poor responses to drug treatment can result in metastasis, cancer dissemination and death. Recently, the epithelial-mesenchymal transition (EMT) has been found to play a critical role in cancer drug resistance, but the nature of this intrinsic link remains unclear. This review summarizes recent advances in the understanding of drug resistance and focuses especially on the association between EMT and drug resistance. We discuss the roles of EMT in regulating drug resistance across different types of cancer, focusing simultaneously on the molecular mechanisms and potential pathways involved in the regulation of drug resistance by EMT. In addition, we discuss potential therapeutic strategies to target EMT to reverse drug resistance.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据